Special Issue: Antibody Therapy for Hematologic Malignancies

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2025-09-27
DOI
https://doi.org/10.3390/ijms26199463
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Special Issue: Antibody Therapy for Hematologic Malignancies

Jonathan P. Butchar
International Journal of Molecular Sciences
Chronic Lymphocytic Leukemia Research
article

Special Issue: Antibody Therapy for Hematologic Malignancies

Jonathan P. Butchar
article en

Abstract

No abstract available for this paper.
International Journal of Molecular SciencesVol. 26(19)
The Ohio State University Wexner Medical Center (US)
National Institutes of Health, National Cancer Institute
Openalex Percentile: Top 63%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Special Issue: Antibody Therapy for Hematologic Malignancies — Jonathan P. Butchar · International Journal of Molecular Sciences (2025) | TGRS Research Map | TGRS